510(k) K893508
K893508 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "PROSTATE SPECIFIC ANTIGEN IMMUNOHISTOCHEMICAL ANTI". The FDA issued a decision of Substantially Equivalent on Aug 4, 1989. The device falls under product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited), a Class II device regulated under 21 CFR 862.1020. Baxter Healthcare Corp has 507 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 4, 1989
- Date Received
- May 5, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Acid Phosphatase (Prostatic), Tartrate Inhibited
- Device Class
- Class II
- Regulation Number
- 862.1020
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Baxter Healthcare Corp? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.